Get the Stockscreener App
74.01
2.48%
-1.88
Pre-market:
74.50
0.49
+0.66%
Solventum Corp stock is traded at $74.01, with a volume of 1.01M.
It is down -2.48% in the last 24 hours and up +0.45% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
See More
Previous Close:
$75.89
Open:
$75.79
24h Volume:
1.01M
Relative Volume:
1.12
Market Cap:
$12.80B
Revenue:
$8.26B
Net Income/Loss:
$66.00M
P/E Ratio:
201.00
EPS:
0.3682
Net Cash Flow:
$1.17B
1W Performance:
-4.91%
1M Performance:
+0.45%
6M Performance:
+7.81%
1Y Performance:
+0.00%
1-Day Range:
$73.48
$76.18
1-Week Range:
$73.48
$80.23
52-Week Range:
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
74.01 | 12.80B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
VEEV
Veeva Systems Inc
|
233.46 | 37.90B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
64.30 | 12.07B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
95.78 | 8.30B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
45.50 | 7.84B | 640.44M | -743.28M | -206.93M | -11.29 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Revolutionary 5-Second Sterilization Test Transforms Hospital Efficiency - StockTitan
March 2025 DE Pearls for Your Practice - Dental Economics
Charles Schwab Investment Management Inc. Has $75.92 Million Holdings in Solventum Co. (NYSE:SOLV) - Defense World
Mutual of America Capital Management LLC Sells 461 Shares of Solventum Co. (NYSE:SOLV) - Defense World
Oppenheimer & Co. Inc. Has $272,000 Holdings in Solventum Co. (NYSE:SOLV) - Defense World
Reviewing Solventum (SOLV) and Its Rivals - Defense World
Solventum (NYSE:SOLV) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Defense World
Solventum Co. (NYSE:SOLV) Shares Sold by US Bancorp DE - MarketBeat
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Morgan Stanley Adjusts Price Target on Solventum to $80 From $73, Maintains Equalweight Rating - Marketscreener.com
Solventum Co. (NYSE:SOLV) Stock Position Lifted by Bank of New York Mellon Corp - Defense World
Head-To-Head Contrast: Solventum (SOLV) vs. Its Peers - Defense World
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum hires chief strategy officer out of Zimmer Biomet - Mass Device
Solventum (NYSE:SOLV) Given New $71.00 Price Target at The Goldman Sachs Group - Defense World
Mizuho Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price - Defense World
Don't Give up on the Turnaround Titan - MD+DI
Solventum Corporation (NYSE:SOLV) Q4 2024 Earnings Call Transcript - MSN
Mizuho Adjusts Price Target on Solventum to $82 From $70, Keeps Neutral Rating -March 03, 2025 at 06:32 am EST - Marketscreener.com
Solventum (NYSE:SOLV) Price Target Raised to $84.00 - Defense World
Solventum (NYSE:SOLV) Price Target Raised to $75.00 - Defense World
Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports - MSN
Positive week for Solventum Corporation (NYSE:SOLV) institutional investors who control 64% of the company - Simply Wall St
Solventum (NYSE:SOLV) Price Target Raised to $84.00 at Piper Sandler - MarketBeat
Is 3M Stock a Buy Now? - The Motley Fool
Anchor Capital Advisors LLC Sells 24,448 Shares of Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum Co. (NYSE:SOLV) Holdings Cut by Pine Valley Investments Ltd Liability Co - MarketBeat
Ieq Capital LLC Acquires 14,780 Shares of Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum Co. (NYSE:SOLV) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Solventum (NYSE:SOLV) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Allspring Global Investments Holdings LLC Trims Stock Position in Solventum Co. (NYSE:SOLV) - MarketBeat
Handelsbanken Fonder AB Takes Position in Solventum Co. (NYSE:SOLV) - MarketBeat
Private Advisor Group LLC Boosts Stock Holdings in Solventum Co. (NYSE:SOLV) - MarketBeat
Facing tariffs and a big sale, Solventum sees profits slide - MSN
Why Solventum (SOLV) Stock Is Down Today - The Globe and Mail
Solventum (NYSE:SOLV) Price Target Raised to $85.00 at Bank of America - MarketBeat
Solventum (NYSE:SOLV) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
What Analysts Are Saying About Solventum Stock - Benzinga India
Solventum (NYSE:SOLV) Releases FY 2025 Earnings Guidance - MarketBeat
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Solventum beats The Street in Q4 — but stock is down - Mass Device
Why Solventum (SOLV) Stock Is Down Today By Stock Story - Investing.com Canada
Thermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unit - MSN
Thermo Fisher Scientific Agreed to Acquire Solventum’s Purification and Filtration Business - Genetic Engineering & Biotechnology News
SOLV Stock Down Despite Q4 Earnings & Revenues Beat Estimates - Yahoo Finance
Solventum: Q4 EPS Beats, Cash Flow Dips - sharewise
Piper Sandler raises Solventum price target to $84, keeps neutral rating By Investing.com - Investing.com South Africa
Biotechnology company Thermo Fisher Scientific buys Solventum’s filtration and purification business for $4.1 billion - BioProcess Insider
Piper Sandler raises Solventum price target to $84, keeps neutral rating - Investing.com
Solventum, facing sagging profit, sells purification business to Thermo Fisher for $4.1 billion - MSN
Stifel Adjusts Price Target on Solventum to $88 From $82, Maintains Buy Rating -February 28, 2025 at 06:37 am EST - Marketscreener.com
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.20%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):